A method to assess invasion and intracellular replication of Trypanosoma cruzi based on differential uracil incorporation

Journal of Immunological Methods

Volumn 220, Issue 1-2, 1998, Pages 123-128

  Yan, Wen ^a   Moreno, Silvia N J ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

L6E9 myoblasts; Trypanosoma cruzi; Uracil incorporation

Indexed keywords

2 AMINO 5 (1 METHYL 5 NITRO 2 IMIDAZOLYL) 1,3,4 THIADIAZOLE; 3A,4,5,6,7,7A HEXAHYDRO 3 (1 METHYL 5 NITRO 1H IMIDAZOL 2 YL) 1,2 BENZISOXAZOLE; BENZNIDAZOLE; FEXINIDAZOLE; GENISTEIN; NIFURTIMOX; URACIL;

ANIMAL CELL; ANTIPROTOZOAL ACTIVITY; ARTICLE; CELL CULTURE; CHAGAS DISEASE; GROWTH INHIBITION; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; RAT; TRYPANOSOMA CRUZI;

ANIMALS; CELLS, CULTURED; DNA REPLICATION; DNA, PROTOZOAN; DRUG EVALUATION, PRECLINICAL; DRUG RESISTANCE; GAMMA RAYS; MUSCLE, SKELETAL; NIFURTIMOX; NITROIMIDAZOLES; RATS; REPRODUCTION; THIADIAZOLES; TRYPANOCIDAL AGENTS; TRYPANOSOMA CRUZI; URACIL;

ANIMALIA; MAMMALIA; PROTOZOA; STAPHYLOCOCCUS PHAGE 3A; TRYPANOSOMA; TRYPANOSOMA CRUZI;

EID: 0031760181     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-1759(98)00155-0     Document Type: Article

References (28)

1. Anonymous, 1991. Control of Chagas' Disease. WHO Tech. Rep. Ser. No. 811.
2. Brener Z. Biology of Trypanosoma cruzi. Annu. Rev. Microbiol. 27:1973;347.
3. Brener Z. Present status of the chemotherapy and chemoprophylaxis of human trypanosomiasis in the western hemisphere. Pharmacol. Ther. 7:1979;71.
4. Buckner F.S., Verlinde C.L.M.J., La Flamme A.C., Van Voorhis W.C. Efficient technique for screening drugs for activity against Trypanosoma cruzi using parasites expressing β-galacosidase. Antimicrob. Agents Chemother. 40:1996;2592.
5. Cançado, J.R., Brener, Z., 1979. Quimioterapia. In: Brener, Z., Andrade, Z. (Eds.), Trypanosoma cruzi e Doença de Chagas. Guanabara Koogan, Rio de Janeiro, p. 362.
6. Cerisola J.A. Evolución serológica de pacientes con enfermedad de Chagas aguda tratados con Bay 2502. Bol. Chil. Parasitol. 24:1969;54.
7. Docampo R., Stoppani A.O.M. Generation of superoxide anion and hydrogen peroxide induced by nifurtimox in Trypanosoma cruzi. Arch. Biochem. Biophys. 197:1979;317.
8. Docampo R., Moreno S.N.J. Biochemical toxicology of antiparasitic compounds used in the chemotherapy and chemoprophilaxis of American trypanosomiasis (Chagas' disease). Rev. Biochem. Toxicol. 7:1985;159.
9. Docampo R., Moreno S.N.J., Vercesi A.E. Effect of thapsigargin on calcium homeostasis in Trypanosoma cruzi trypomastigotes and epimastigotes. Mol. Biochem. Parasitol. 59:1993;305.
10. Ferreira A.O. Tratamento da forma indeterminada da doença de Chagas com nifurtimox e benznidazol. Rev. Soc. Bras. Med. Trop. 23:1990;209.
11. Filardi L.S., Brener Z. A nitroimidazole-thiadiazole derivative with curative action in experimental Trypanosoma cruzi infections. Ann. Trop. Med. Parasitol. 76:1982;293.
12. Galel S.A., Kirchhoff L.V. Risk Factors for Trypanosoma cruzi infection in California blood donors. Transfusion. 36:1996;227.
13. Harris C., Salgo M.P., Tanowitz H.B., Wittner M. In vitro assessment of antimicrobial agents against Toxoplasma gondii. J. Infect. Dis. 157:1988;14.
14. Kirchhoff L.V. American Trypanosomiasis (Chagas' disease) - a tropical disease now in the United States. New Engl. J. Med. 329:1993;639.
15. Mack D.G., McLeod R. New micromethod to study the effect of antimicrobial agents on Toxoplasma gondii: comparison of sulfadoxine and sulfadiazine individually and in combination with pyrimethamine and study of clindamycin, metronidazole and cylcosporin A. Antimicrob. Agents Chemother. 26:1984;26.
16. Malanga C.M., Conroy J., Cuckler A.C. Therapeutic efficacy of several nitroimidazoles for experimental Trypanosoma cruzi infections in mice. J. Parasitol. 67:1981;35.
17. Marr J.J., Docampo R. Chemotherapy for Chagas' disease: a perspective of current therapy and considerations for future research. Rev. Infect. Dis. 8:1986;884.
18. Moreno S.N.J., Docampo R., Mason R.P., Leon W., Stoppani A.O.M. Different behaviors of benznidazole as free radical generator with mammalian and Trypanosoma cruzi microsomal preparations. Arch. Biochem. Biophys. 218:1982;585.
19. Murray P.K., Habbersett M.C., Meurer R.D. Trypanosoma cruzi: efficacy of the 2-substituted, 5-nitroimidazoles, MK-436 and L-634,549, in tissue culture an mice. Am. J. Trop. Med. Hyg. 32:1983;1242.
20. Nussenzweig, V., Sonntag, R., Biancalana, A., Pedreira de Fleitas, J.L., Amato Neto, V., Kloetzel, J., 1953. Acão de corantes trifenil-metanicos sobre o Trypanosoma cruzi 'in vitro'. Emprêgo de violeta de genciana na profilaxia da transmissão da moléstia de chagas por transfusão de sangue, Vol. 44. Hospital, Rio de Janeiro, p. 731.
21. Pfefferkorn E.R., Pfefferkorn L.C. Specific labeling of intracellular Toxoplasma gondii with uracil. J. Protozool. 24:1977;449.
22. Polak A., Richle R. Mode of action of the 2-nitroimidazole derivative benznidazole. Ann. Trop. Med. Parasitol. 72:1978;45.
23. Raether W., Seidenath H. The activity of fexinidazole (HOE 239) against experimental infections with Trypanosoma cruzi, trichomonads and Entamoeba histolytica. Ann. Trop. Med. Parasitol. 77:1993;13.
24. Rodriguez J.B., Gros E.G. Recent developments in the control of Trypanosoma cruzi, the causative agent for Chagas' disease. Curr. Med. Chem. 2:1995;723.
25. Schmatz D.M., Murray P.K. Cultivation of Trypanosoma cruzi in irradiated muscle cells: improved synchronization and enhanced trypomastigote production. Parasitology. 85:1982;115.
26. Schmuñis G.A., Szarfman A., Coarasa L., Guilleron C., Peralta J.M. Anti-Trypanosoma cruzi agglutinins in acute human Chagas' disease. Am. Soc. Trop. Med. Hyg. 29:1980;170.
27. Tanowitz H.B., Wittner M., Chen B., Huang H., Weiss L.M., Christ G.J., Braunstein V., Bilezikian J.P., Morris S.A. Effects of verapamil on acute murine Chagas' disease. J. Parasitol. 82:1996;814.
28. Vieira M.C.F., de Carvalho T.U., de Souza W. Effect of protein kinase inhibitors on the invasion process of macrophages by Trypanosoma cruzi. Biochem. Biophys. Res. Commun. 203:1994;967.